Idex biometry interim report for the fourth quarter and provisional result for 2024

Oslo, Norway: The interim report of IDEX Biometrics ASA for the fourth quarter and the preliminary result 2024 is attached to this message, including the presentation of the fourth quarter of 2024.

The report and the presentation can be found on the IDEX biometry website:

www.idexbiometrics.com/investors

Longest highlights

• Certification of the IDEX Pay platform enables manufacturers to certify and start biometric payment card programs with Visa and MasterCard worldwide.
• Reaching the scale quality of manufacture among the most important partners and enables you and us to go beyond the pilot volume.
• IDEX Biometrics Partner Kona I is certified as the first manufacturer of MasterCard for PVC and metal biometry cards.
• Access: received an order of digaware to provide a biometric sensor solution to improve your intelligent badges. The new biometric ID badge of Digaware contains RFID radios for emergency situations in environments such as schools, hospitals and companies.
• Payments: First commercial start in Japan together with Life Card, daughter of the third largest consumer financing company Japan. The commercial introduction of Life Card is targeted for the first half of 2025.
• Optimized global operations and turned to cost efficiency, resources with the most important market priorities and further optimized our workforce.
• Completion law output in November, so that retail investors take part in the same conditions as shareholders who take part in the September capital survey.

Financial results Q4 2024

• No product income in the fourth quarter.
• The operating costs in the conclusion of the sold products and the provisions of the default losses were $ 2.4 million in the fourth quarter, under the aim of $ 2.5 million.
• A delimitation for the loss of demands from Zwipe in the amount of USD 0.6 million was recorded in the fourth quarter of 2024.
• The net loss in the fourth quarter of 2024 was 2.1 million dollars. The result includes the financial net profit of USD 2.4 million, which is caused by the value change of the option certificates, and derivative in connection with the convertible debt. The result would have been a net loss of 4.6 million US dollars.
• In the fourth quarter, a non-cash impairment of the good will of $ 968 was recorded.
• CARE credit per December 31, 2024 at USD 2.0 million

For more information, please contact:

Marianne Bøe, head of investor relationships, +47 91800186

Kristian Flälen, CFO + 47 9509232222

E-mail: [email protected]

About ideex biometry

IDEX BIOMETRICS ASA (OSE: IDEX) is a global technology leader in fingerprint biometry and offers authentication solutions for payments, access control and digital identity. Our solutions bring comfort, security, peace of mind and seamless user experiences into the world. Building on patented and proprietary sensor technologies, integrated circuit structures and software, our biometric solutions aim at card -based applications for payments and digital authentication. As an industry improvement, we work with leading map manufacturers and technology companies to launch our solutions.

You can find more information at www.idexbiometrics.com (http://www.idexbiometrics.com)

Brand declaration

IDEX, Trustedbio, Idex biometry and the IDEX logo are brands of the IDEX -Biometrics ASA. All other brands or product names are the property of their respective owners.

About this note

This notification was issued on February 27, 2025 at 8:00 a.m. on behalf of IDEX Biometrics ASA by Marianne Bøe, head of the investor relations. The information will be announced in accordance with Section 5-6 of the Norwegian Securities Trading Act (StA) and published in accordance with Section 5-12 of the StA.

Attachment

• Idex biometry Q4 2024 report

• Idex biometry Q4 2024 presentation